Skip to main content

Table 1 Vaccine Scenarios for the 4-strain model

From: The impact of aggregating serogroups in dynamic models of Neisseria meningitidis transmission

4-strain Vaccine Scenarios

 

Age of Immunization

Vaccine Type

Efficacy

Coverage

1

12 months

C

97 %

90 %

2

12 years

C

97 %

80 %

3

12 months and 12 years

C

97 %

90 %/80 %

4

12 months

MCV-4

97 %

90 %

5

12 years

MCV-4

97 %

80 %

6

12 months and 12 years

MCV-4

97 %

90 %/80 %

7

12 months

4CMenB

64 %

90 %

8

12 years

4CMenB

64 %

80 %

9

12 months and 12 years

4CMenB

64 %

90 %/80 %

  1. The efficacy of the conjugate C vaccine and the MCV-4 vaccine are assumed to be 97 % [41, 46]. The 4CMenB vaccine efficacy is assumed to be 64 % based on [44]. The duration of vaccine protection is assumed to be 4 years
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us